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Bone morphogenetic proteins (BMPs), members of the transforming growth factor-b (TGF-b) superfamily, are obligatory
growth factors for early embryogenesis and heart formation. SMAD proteins transduce signals of the TGF-b superfamily. We
solated chicken Smad6 (cSmad6), a member of inhibitory SMADs, and found its expression to be remarkably restricted to
he developing heart, eyes, and limbs. cSmad6 expression was detected in the cardiogenic region of stage 5 embryos and
verlapped Nkx2-5 and bmp-2, -4, and -7 expression. Throughout development, cSmad6 was expressed strongly in the heart,
rimarily in the myocardium, endocardium, and endocardial cushion tissue. Myocardial expression of cSmad6 was stronger
n the forming septum, where highly localized expression of bmp-2 and -4 was also observed. Ectopically applied BMP-2
rotein induced the expression of cSmad6, a putative negative regulator of BMP-signaling pathway, in anterior medial
esoendoderm of stage 4–5 embryos. In addition, blocking of BMP signaling using Noggin downregulated cSmad6 in
ardiogenic tissue. cSmad1, one of the positive mediators of BMP signaling, was also expressed in cardiogenic region, but
as not BMP-2 inducible. Our data suggest that cSmad6 has a role in orchestrating BMP-mediated cardiac development. We
ropose the possible mechanism of action of cSmad6 as modulating BMP signal by keeping a balance between constitutively
xpressed pathway-specific cSmad1 and ligand-induced inhibitory cSmad6 in the developing heart. © 1999 Academic Press
Key Words: bone morphogenetic protein; inhibitory SMAD; Smad6; Smad1; cardiac development; chick embryo.
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BINTRODUCTION
Bone morphogenetic proteins (BMPs) are members of the
transforming growth factor-b (TGF-b) gene family and play
multiple roles during morphogenesis and pattern formation
in vertebrate embryos (Lyons et al., 1990; Jones et al., 1991;
reviewed in Hogan, 1996). Recently SMAD proteins have
been identified as signal transducers of the TGF-b super-
family (reviewed in Heldin et al., 1997; Kretzchmar and
Massague´, 1998; Whitman, 1998). To date, 10 different
Smad genes have been isolated (Heldin et al., 1997; Whit-
man, 1998; LeSueur and Graff, 1999) that have been catego-
rized into three subgroups (reviewed in Heldin et al., 1997).
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48The first subgroup encodes pathway-specific signal-
transducing SMADs, which consists of Smad1, Smad5, and
Smad8 that mediate BMP signaling and Smad2 and Smad3
that mediate TGF-b and activin signaling. These positive
mediators are phosphorylated at a carboxy-terminal SSXS
consensus motif by ligand-bound type I receptor
(Kretzschmar et al., 1997; Macias-Silva et al., 1996) and
subsequently form a heterodimer with Smad4 (Lagna et al.,
1996; Zhang et al., 1996, 1997). Smad4 is a member of the
second subgroup of SMAD proteins and binds to all
pathway-specific SMADs. Heterodimers formed between
pathway-specific SMADs and Smad4 translocate into the
nucleus (Kretzschmar et al., 1997; Macias-Silva et al., 1996)
nd transactivate specific target genes (Liu et al., 1996). The
hird subgroup of the SMAD family is composed of inhibi-
ory SMADs, which antagonize the function of the
athway-specific SMADs (reviewed in Whitman, 1997). In
ertebrates, Smad6 and Smad7 function as inhibitors of
MP, TGF-b, and activin signaling (Imamura et al., 1997;Topper et al., 1997; Hata et al., 1998; Kleeff et al., 1999).
Whereas Smad7 acts as an inhibitor of signaling by all
0012-1606/99 $30.00
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49Smad6 in Chick Cardiac DevelopmentTGF-b family members (Nakao et al., 1997; Hayashi et al.,
1997; Bhushan et al., 1998), Smad6 appears to be an inhib-
itor of BMP signaling (Hata et al., 1998). TGF-b/BMP
signaling is inhibited by Smad6 and Smad7 because these
proteins bind to type I receptors with greater affinity than
the pathway-specific SMADs and thereby prevent phos-
phorylation of the pathway-specific SMADs (Imamura et
al., 1997; Hayashi et al., 1997; Nakao et al., 1997). More-
ver, Smad6 competes with Smad4 for binding to receptor-
ctivated Smad1, yielding an inactive Smad1–Smad6 com-
lex (Hata et al., 1998).
Even though BMP and TGF-b proteins are clearly in-
volved in embryogenesis (reviewed in Hogan, 1996), little is
known about the expression pattern and the roles of the
various SMADs during embryogenesis (reviewed in Heldin
et al., 1997; Whitman, 1998). In the mouse embryo Smad1
and Smad2 are expressed at high levels in a variety of
developing organs at sites where epithelial–mesenchymal
interactions occur (Dick et al., 1998). A brief description of
the pattern of expression of Smad6 was reported for Xeno-
pus embryos (Nakayama et al., 1998a). Xenopus Smad6
(xSmad6) transcripts are found in parts of the dorsal neural
tube, the dorsal part of the eye, the otocyst, and the heart
anlage (Nakayama et al., 1998a). Deletions of the bmp-2
and bmp-4 genes in mice result in early embryonic death. In
the case of bmp-22/2 mice, amnion and chorion formation
and cardiac development are abnormal (Zhang and Bradley,
1996). bmp-42/2 and ALK3 (BMP type I receptor) 2/2
mice exhibit little or no mesodermal differentiation (Win-
nier et al., 1995; Mishina et al., 1995). Recently Smad2,
Smad4, and Smad5 genes have been knocked out in the
mouse with the result of early embryonic lethality. Ho-
mozygous Smad4 mutants fail to gastrulate, do not express
mesodermal markers, show abnormal visceral endoderm
development, and die before E8.5 (Yang et al., 1998; Siraard
et al., 1998). Mice that lack Smad2 also fail to undergo
gastrulation and do not make normal mesoderm (Waldrip et
al., 1998; Nomura et al., 1998; Weinstein et al., 1998).
Smad5 knockout mice showed a less severe phenotype than
mutant mice lacking BMPs, Smad2, or Smad4, but they
eventually died at E9.5–11.5 with cardiac defects similar to
bmp-2 knockout mice or impaired vasculogenesis/
hematopoesis (Chang et al., 1999). Taken together, these
findings suggest that BMPs and their downstream signal
transducers, the SMADs, are required for gastrulation and
mesoderm formation.
The heart is among the first functional organs that arise
from mesoderm. Drosophila tinman is a mesoderm-specific
homeobox gene (Bodmer et al., 1990) that is required for
midgut and heart formation (Azpiaazu and Frasch, 1993;
Bodmer, 1993). Decapentaplegic (Dpp), a Drosophila ho-
molog of bmp-2 and -4, is required for the expression of
tinman and is thought to determine which cells of the
mesoderm become competent to develop into visceral me-
soderm and the heart (Frasch, 1995). The 39-flanking region
of the tinman gene contains binding sites for the Medea and
Mad proteins, the Drosophila homologs of Smad4, and of
Copyright © 1999 by Academic Press. All rightpathway-specific SMADs, respectively (Xu et al., 1998).
Medea mutant embryos show significant reduction of tin-
man expression in prospective cardiac mesoderm indicating
a requirement for Medea to activate tinman expression in
response to Dpp. A vertebrate homolog of tinman, Nkx2-5
(reviewed in Harvey, 1996), is the earliest known marker of
mesoderm fated to give rise to myocardium (Schultheiss et
al., 1995). Murine Nkx2-5 null mutants form a rudimentary
heart tube that subsequently fails to loop and form a
four-chamber heart. Therefore, these embryos die of cardiac
failure by E10–11.5 (Lyons et al., 1995; Tanaka et al., 1999).
This cardiac phenotype is similar to that seen in bmp-22/2
mouse embryos that develop to E9.5 (Zhang and Bradley,
1996). In addition, BMP-2 ectopically applied to noncardio-
genic region of early chick embryos induces Nkx2-5 as well
as other cardiac marker genes such as GATA4 and MHC
(Schultheiss et al., 1997; Andre´e et al., 1998). These find-
ings in Drosophila and vertebrates implicate the impor-
tance of BMP signaling in vertebrate heart development but
the potential role of SMAD proteins in cardiac development
has not yet been addressed in vertebrates and is the focus of
the present study.
We have isolated a chicken Smad6 cDNA as well as
partial cDNAs of several other chicken Smad genes using
RT-PCR and determined their expression patterns during
early chick embryogenesis. We found that chicken Smad6
(cSmad6), one of the inhibitory SMADs, was expressed
strongly in the developing heart, eyes, and limbs. In par-
ticular, during the period of cardiac induction, cSmad6
expression overlapped the expression of bmp-2, -4, and -7.
We found that locally released BMP-2 protein induced
cSmad6 in anterior medial mesoderm, a region that re-
sponded to BMP-2 by expressing cardiac marker genes
(Nkx2-5, GATA4, MHC; see Schultheiss et al., 1997; An-
dre´e et al., 1998). BMP-pathway-specific cSmad1 was also
expressed in cardiogenic region, but was not BMP-2 induc-
ible. Incubation of cardiogenic mesoendoderm with Nog-
gin, an antagonist of BMP signaling (Zimmerman et al.,
1996), decreased the level of cSmad6 expression. These data
suggest an important role of cSmad6 in orchestrating BMP-
mediated cardiac development. We propose the possible
mechanism of action of cSmad6 as modulating BMP signal
by keeping a balance between constitutively expressed
pathway-specific cSmad1 and ligand-induced inhibitory
cSmad6 in the developing heart.
MATERIALS AND METHODS
Isolation of a cSmad6 cDNA
Total RNA was isolated from stage 18–21 (Hamburger and
Hamilton, 1951) chicken embryos. First-strand cDNA was synthe-
sized using random primers and AMV reverse transcriptase. PCR
was carried out using the degenerate oligonucleotides 59-
AGTACAAGCCACTGGATCTGTCCGA-39 (forward) and 59-
CCAGCCCTTGGCGAAGCTGATGC-39 (reverse) (arrows in Fig.
1A). The PCR conditions were 94°C, 4 min and then 35 cycles of
s of reproduction in any form reserved.
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50 Yamada et al.94°C, 20 s; 55°C, 30 s; 72°C, 60 s; and final extension by 72°C, 10
min. PCR products were run on a 1% agarose gel, isolated, and
subcloned into pCRscript-SK(1) vector (Strategene). The 590-bp
PCR fragment generated was used to screen one million plaques
from a lambda-ZAP phage cDNA library prepared from stage 14–17
chick embryos. Isolated clones were sequenced using an
AmpliTaq-FS dye terminator cycle sequencing kit (Perkin Elmer)
and an ABI-Prism377 sequencer (PE-Applied Biosystems). Partial
chicken Smad1 and Smad5 cDNAs (cSmad1, cSmad5) were iso-
ated by RT-PCR (Accession Nos.: cSmad1, AF143239; cSmad5,
F143240; cSmad6, AF165889).
Expression Analysis by in Situ Hybridization
Chick embryos at stage 4–30 were fixed in MEMFA fixative (0.1
M Mops, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde) and
stored at 220°C until use as described (Albrecht et al., 1997).
ynthesis of digoxigenin-labeled RNA probes corresponding to
Smad6, cSmad1, cSmad5, Nkx2-5 (Schultheiss et al., 1995),
BMP-2 (Fransis et al., 1994), BMP-4 (Roberts et al., 1995), and
BMP-7 (Oh et al., 1996) was performed with a Strategene RNA
labeling kit as described previously (Albrecht et al., 1997). All
probes were alkaline hydrolyzed to the size of ;300 bp in order to
enhance probe penetration (Angerer and Angerer, 1992) and whole-
mount in situ hybridization was carried out following the protocol
described in Albrecht et al. (1997) except that polyvinyl alcohol
was included to increase signal (Barth and Ivarie, 1994). Following
color development, 10-mm sections were cut from paraffin-
mbedded whole mounts. In situ hybridization on paraffin sections
as carried out using 35S-labeled riboprobes as described (Albrecht
et al., 1997). Seven-micrometer sections were hybridized at 58°C
overnight, and stringency washes were performed at 67°C. Slides
were dipped in NTB-2 emulsion and exposed for 2–3 days. Tissue
was visualized by Hoechst dye staining of nuclear DNA. Silver
grains were visualized in the dark field were represented in false
colors in figures.
BMP-2 Application
Rat bone matrix particles obtained from Genetics Institute
(Cambridge, MA) or heparin–acrylamide beads (Sigma H-5263)
were soaked in 1 ml of 30–90 mg/ml solution of human recombinant
MP-2 (Genetics Institute) overnight at 4°C in a moist chamber.
eads soaked in carrier protein (0.1% bovine serum albumin) were
sed as a control. Stage 5 embryos were placed ventral side up on
lbumin–agar plates (Sundin and Eichele, 1992), and BMP-2 carriers
ere implanted to the anterior medial area of the embryos as
reviously described (Schultheiss et al., 1997). Embryos were
ncubated for 4–9 h, fixed with MEMFA as described above, and
rocessed for whole-mount in situ hybridization.
Explant Cultures
Tissues were dissected from chick embryos with tungsten
needles (Sugi et al., 1993) and cultured in type I collagen gels
Becton Dickinson, Bedford, MA) (Schultheiss et al., 1997; Selleck
et al., 1998) in wells of a Lab-Tek chamber slide (Nunc No. 178599).
Anterior medial explants from stage 5–6 embryos were used for the
BMP-2 treatment. Explants were cultured in M199 medium con-
taining 10% fetal bovine serum and 1% penicillin/streptomycin
with or without BMP-2 protein. Anterior lateral mesoendoderm
from stage 4–5 embryos was used for the Noggin experiments.
(
p
Copyright © 1999 by Academic Press. All rightNoggin-conditioned medium was harvested from CHO cells stably
transfected with Xenopus noggin (Lamb et al., 1993). Control
conditioned medium was prepared from parental CHO cell line.
Noggin and control media were added to explants and supple-
mented with fetal bovine serum to a final serum concentration of
10%. Explants were cultured in a humidified incubator at 37°C and
5% CO2 until evaluation.
Reverse Transcription (RT)-PCR Analysis
RT-PCR analysis was performed as described previously (Schul-
theiss et al., 1995; Yatskievych et al., 1997). RNA was harvested
from explant cultures by using RNeasy kit (Qiagen, Valencia, CA).
RT reactions were performed in a 40-ml volume using random
hexamers and 200 U of Superscript reverse transcriptase (Life
Technologies). PCR reactions were carried out in a volume of 25 ml,
sing PCR buffer (Perkin–Elmer, Foster City, CA), 1.25 U of Taq
olymerase (Perkin–Elmer), 1.5 mM MgCl2, 0.2 mM each dNTP
(Boehringer Mannheim), 0.4 mM of each primer, and one-tenth of
reverse transcribed cDNA. The primers for the genes to amplify
GAPDH and Nkx2-5 were those described by Schultheiss et al.
(1995). The primer pair for cSmad6 was 59-CCAGAGTCTCCGC-
CGCCTCCCTACTCC-39 (forward) and 59-CCTTTCGTCAGAG-
GCTGACTGTTATCG-39 (reverse) corresponding to nucleotides
922–948 and 1597–1623 of chicken Smad6, designed to amplify a
702-bp PCR product. Amplification was carried out by a shortened
program (Mai et al., 1998) as follows: (1) denaturation at 94°C for 2
min; (2) cycles of denaturation (94°C, 2 s), annealing (56°C for
GAPDH and cSmad6, 51°C for Nkx2-5, 5 s), and extension (72°C,
s); and (3) final extension at 65°C for 10 min. The cycle number
or each primer pair was chosen to fall within the linear range of
mplification using positive control RNA samples. To test for the
bsence of contaminating genomic DNA, RNA samples, which
ere not reverse transcribed, were simultaneously processed. For
isualization, one-third of each PCR product was electrophoresed
n a 1% agarose gel and stained with ethidium bromide. Alterna-
ively, PCR was performed with 0.1 ml of [a-32P]dCTP, and products
ere separated on a 6% polyacrylamide gel. Dried gels were
xposed overnight to X-ray film.
RESULTS
Isolation and Characterization of the Chicken
Smad6 cDNA
A partial cSmad6 cDNA was obtained using a RT-PCR
based strategy, and subsequently this fragment was used to
screen a chick cDNA library (see Materials and Methods).
The longest isolated cDNA was 1967 nucleotides (nts) in
length that included 1296 nts of an open reading frame
encoding 431 amino acids (Fig. 1A), 306 nts of 59-
untranslated region, and 365 nts of the 39-untranslated
region. BLAST search revealed that the protein encoded by
this cDNA had a significant similarity to Smad6 and Smad7
proteins of other species. The highest degree of homology
was observed with human Smad6 (hSmad6) (P(N 5 e2170),
mouse Smad6 (mSmad6) (P(N) 5 e2168), and Xenopus Smad6
(xSmad6) (P(N) 5 e2134), followed by human Smad7
hSmad7)(P(N) 5 e2107). The overall identity of the chicken
rotein amino acid sequence was 64% with hSmad6, 62%
s of reproduction in any form reserved.
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51Smad6 in Chick Cardiac Developmentwith mSmad6, and 69% with xSmad6, followed by 46–47%
with Smad7 proteins of other species. This suggests that the
chicken cDNA encodes the chick homolog of Smad6.
Further examination of chicken Smad6 (cSmad6) protein
revealed conserved SMAD structural domains (Fig. 1B).
SMAD proteins typically consist of three regions: the
highly conserved N- and C-terminal domains termed MH1
and MH2 and a less-conserved linker (reviewed in Heldin et
l., 1997). Although the MH1 domain of the putative
Smad6 shared only 44–46% identity with mSmad6 and
Smad6 (Fig. 1B), the first 18 amino acids of the avian MH1
omain were 100% identical to those of the human and
ouse Smad6 proteins. Residues 19 to 93 were poorly
onserved, but the following amino acids extending from
lu 94 to the C-terminus of MH1 (Pro 206) were highly
onserved (56–73% identity). The linker region of the
utative cSmad6 (Glu 207 to Ser 263) had no similarity with
athway-specific SMADs or with Smad4, but this region
as conserved amongst the Smad6 proteins of different
pecies (Fig. 1B). In particular, the ESP(P/T)PPYXR motif
ocated at the N-terminus of the linker region was identical
FIG. 1. Structure of chicken Smad6 (cSmad6) protein. (A) Predicted
used for the initial cloning of a cSmad6 fragment. (B) Diagram of
sequences with human (h), mouse (m), and Xenopus (x) Smad6 ino that in all other Smad6 and Smad7 proteins. The MH2
omain of the putative cSmad6 (His 264 to C-terminus)
Copyright © 1999 by Academic Press. All righthowed high similarity to all known SMADs including the
athway-specific SMADs. The highest homology, however,
esided with hSmad6, mSmad6, and xSmad6. The putative
Smad6 lacked the SSXS motif found at the end of the MH2
omain of the pathway-specific SMADs. This motif serves
s a receptor phosphorylation site and its absence is a
allmark of inhibitory SMADs (Kretzschmar and Massague´,
998). Taken together, sequence homology and the pres-
nce or absence of certain features strongly suggests that
he isolated chicken cDNA encodes the chicken Smad6
rotein, one of several known inhibitory SMADs.
Temporal and Spatial Expression Pattern
of cSmad6 in the Developing Heart
In order to determine the spatiotemporal expression of
cSmad6, whole-mount in situ hybridization was performed
on Hamburger–Hamilton stage 4 to 30 chick embryos.
Expression of cSmad6 was first detected at stage 4 in the
posteriormost part of the primitive streak and at the margin
of the embryo (Fig. 2A) in a region of prospective extraem-
no acid sequence of cSmad6. Arrows indicate regions of the primers
omain structure of cSmad6. Percentage of identity in amino acid
of the regions is indicated.amibryonic tissue (Garcia-Martinez and Schoenwolf, 1993).
Expression in these domains increased by stage 5 (Fig. 2B), a
s of reproduction in any form reserved.
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52 Yamada et al.stage at which cSmad6 mRNA also began to appear in an
anterior lateral region in a crescent-shaped pattern, previ-
ously described as a cardiogenic region or a cardiac crescent
(Rosenquist and DeHaan, 1966; Ehrman and Yutzey, 1999).
Expression in the crescent was identical to that of Nkx2-5
(compare Figs. 2B and 2G), the earliest known marker gene
for cardiogenic tissue (Schultheiss et al., 1995). Unlike
Nkx2-5, cSmad6 expression at this stage was found not
only in cardiogenic mesoderm but also in the underlying
endoderm (data not shown). At stage 7, the expression
pattern of cSmad6 was similar to that seen at earlier stages,
FIG. 2. Expression pattern of cSmad6, bmp-2, bmp-4, bmp-7, and
ottom right corner of each photograph. (A) The expression of cSm
he lateral margins of the embryo. (B) By stage 5, cSmad6 is express
n this region was increased by stage 7 (C). The expression pattern
bmp-4 (E), bmp-7 (F), and Nkx2-5 (G) during these early stages. (H)
ubes. Sections of stage 8 embryo (O), at the level indicated in (H) b
o the anterior lateral plate mesoderm and the underlying endoder
as highly expressed throughout the primitive heart tube, both
ersisted in the heart tube even after looping had started (J, Q), sim
xpressed in the heart itself, except for the expression of bmp-2 in v
mp-7 (M) was still expressed in the heart, in a pattern similar to
c, endocardium; ect, ectoderm; end, endoderm; h, heart; hn, Hens
itellin veins.ut transcript levels were further increased in the cardiac
egion, while expression in the posterior part of embryo
2
Copyright © 1999 by Academic Press. All rightecame more diffuse (Fig. 2C). At stage 8, cSmad6 expres-
ion was very pronounced in the nascent bilateral heart
ubes (Fig. 2H) and in the posteriormost tip of the primitive
treak (data not shown). Cross-sections at this stage showed
Smad6 transcripts in anterolateral splanchnic mesoderm
nd the underlying endoderm (Fig. 2O). After stage 8,
ilateral heart tubes begin to fuse at the midline, and a
ingle primitive straight heart tube is formed. During for-
ation of the single heart tube and later, cSmad6 was
trongly expressed throughout the entire heart (Figs. 2I and
J), both in the myocardium and in the endocardium (Figs.
-5 in chick embryos at stages 4 to 11. The stage is indicated in the
was first observed at stage 4 in the posterior primitive streak and
the anterior lateral cardiogenic region; the intensity of expression
mad6 in this cardiogenic region was similar to that of bmp-2 (D),
age 8, cSmad6 was expressed highly in the nascent bilateral heart
ed horizontal line, revealed that cSmad6 expression was localized
) By stage 10, when fusion of the heart tubes is complete, cSmad6
e myocardium and in the endocardium (P). cSmad6 expression
o Nkx2-5 (N). In contrast, bmp-2 (K) and bmp-4 (L) were no longer
ne veins, after completion of primitive heart tube formation. Only
of cSmad6. Abbreviations: cr, cardiogenic region; da, dorsal aorta;
node; mc, myocardium; mes, mesoderm; ps, primitive streak; vv,Nkx2
ad6
ed in
of cS
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in th
ilar t
itelli
thatP and 2Q).
SMAD proteins are known to mediate BMP signal trans-
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53Smad6 in Chick Cardiac Developmentduction (reviewed in Whitman, 1998). Therefore, we com-
pared the expression of cSmad6 with that of several BMPs
expressed in the cardiac region (Schultheiss et al., 1997).
The transcripts of bmp-2, -4, and -7 were detected in the
cardiogenic region at stage 5 to 6 (Figs. 2D–2F), and expres-
sion resembled that of cSmad6 (Fig. 2B). bmp-2 is endoderm
specific, whereas bmp-4 and -7 are expressed only in ecto-
derm (Schultheiss et al., 1997). cSmad6 transcripts were
found in endoderm and mesoderm (Fig. 2O), but since BMPs
are secreted factors any of the three BMPs could enter tissue
that expressed cSmad6. Until stage 6, the location of
cSmad6 expression overlapped with those of bmp-2, -4, and
-7. Thereafter, the patterns of expression diverged. By stage
10, when the formation of a primitive straight heart tube
was completed, bmp-2 expression in the heart had disap-
peared except in the vitelline veins (Fig. 2K). Likewise,
expression of bmp-4 was no longer detectable in the heart
(Fig. 2L). bmp-7 (Fig. 2M) and cSmad6 (Fig. 2I) transcripts,
however, were present throughout the heart.
At stage 11 when the heart started looping to the right,
cSmad6 was strongly expressed in the entire heart (Fig. 2J)
and in the dorsal aorta and the dorsal wall of the vitelline
veins, both of which were connected to the heart (Figs. 2J
and 2Q and data not shown). cSmad6 expression in the
developing heart persisted at least to stage 28, in the
myocardium and in the endocardium.
To investigate cSmad6 expression at later stages of heart
development, in situ hybridization was conducted on tissue
sections. We were particularly interested in the overlapping
pattern of expression of cSmad6 and BMPs, since BMPs
were considered to be involved in the process of septation at
this stage (reviewed in Eisenberg and Markwald, 1995;
Yamagishi et al., 1998). After the formation of the straight
heart tube, the looping process follows, and subsequently
each chamber of the heart starts to be separated by septum
formation to eventually form a complete four-chamber
heart (Bellairs and Osmond, 1998; Colvin, 1990). At stage
17, a subpopulation of endocardial cells located at the
junction of the primitive atrium and ventricle undergoes a
transformation to mesenchymal cells (Bolender and Mark-
wald, 1979). These cells then invade the underlying extra-
cellular matrix and therein form endocardial cushion tis-
sue. This cushion tissue consists of two components; the
atrioventricular cushion (AV cushion), which contributes
to the formation of atrioventricular septum and valves, and
the outflow tract cushion (OT cushion), which forms aor-
ticopulmonary septum (Keyes and Sanders, 1999). These
cushions are essential elements for septation and valve
formation accomplished by stage 34. Mesenchymal trans-
formation that generates the cushion tissue is thought to be
regulated by signaling molecules secreted by the underlying
myocardium (Krug et al., 1987; Markwald et al., 1990).
everal BMPs and other TGF-b family members are ex-
pressed in these valve- and septum-forming regions (Lyons
et al., 1990; Jones et al., 1991; Nakajima et al., 1994, 1998;amsdell and Markwald, 1997) and may mediate the above-
escribed processes.
Copyright © 1999 by Academic Press. All rightAt stage 20, when the formation of endocardial cushion
ad begun, cSmad6 was expressed throughout the entire
eart (Fig. 3A). Expression was particularly strong in the
yocardium at the atrioventricular junction, where highly
ocalized bmp-2 expression was also observed (Fig. 3B).
mp-4 was not expressed at this stage (data not shown), but
mp-7 was expressed in the myocardium throughout the
ntire heart (Fig. 3C), which was also the case for Nkx2-5
Fig. 3D).
At stage 26–28, when the septation process was close to
ompletion, bmp-2 expression was highly restricted to the
yocardium at the nascent interatrial septum, the atrio-
entricular grooves, the tip of interventricular septum (Fig.
F), and the aorticopulmonary septum (Fig. 3K). cSmad6
xpression was seen throughout the heart, not only in the
yocardium and endocardium, but also in the endocardial
V cushion (Fig. 3E). Expression was high in the regions
orming a ventricular septum and the aorticopulmonary
eptum (Figs. 3I and 3J). Interestingly, the OT cushion,
nlike the AV cushion, never expressed cSmad6 (Fig. 3J).
kx2-5 was expressed only in the myocardium, but not in
he endocardial cushion (Fig. 3H). In comparison, the ex-
ression of bmp-4 reappeared at this stage and was even
ore restricted than bmp-2, being found only in the myo-
ardium surrounding the OT cushion (data not shown).
nother BMP member, bmp-7, showed ubiquitous expres-
ion in myocardium, with clear border between conus
uscle and truncal muscle (Figs. 3G and 3L). The expres-
ion of bmp-2, -4, and -7 covered all areas of cSmad6
xpression, except for the endocardial cushion. Figure 3N
ummarizes the overlapping patterns of expression of
Smad6 and bmp-2, -4, and -7 at stage 26–28.
Temporal and Spatial Expression Pattern of
cSmad6 during Eye and Limb Development
cSmad6 expression was also observed in developing eyes,
limbs, somites, and lungs. Because BMP-2, -4, and -7 are
implicated in eye and limb development (Dudley et al.,
1995; Luo et al., 1995; Solursh et al., 1996; Furuta and
Hogan, 1998; Wawersik et al., 1999; Fransis et al., 1994;
Hogan, 1996), we briefly describe cSmad6 expression pat-
terns in these tissues. The expression in the prospective eye
was first seen at stage 10 (Fig. 4A) in the neuroepithelium of
optic vesicles (Fig. 4D). As the surface ectoderm contacting
the optic vesicle started to form lens placode, cSmad6
mRNA began to be expressed in the placode (Fig. 4E).
Expression in the optic cup decreased during stage 13 (Fig.
4B), and cSmad6 was no longer detectable in the optic cup
by stage 17 (Figs. 4C and 4F) but only in the dorsal portion
of the lens vesicle (Fig. 4F). cSmad6 was also expressed in
developing limbs. At stage 14, expression was seen uni-
formly along the entire flank in the lateral plate mesoderm
(data not shown). By stage 18, expression disappeared in the
interlimb flank but increased in the nascent limb buds (Fig.
4G). As the limb buds extended distally, the signal became
concentrated to the mesenchyme underneath the apical
s of reproduction in any form reserved.
54 Yamada et al.FIG. 3. Comparison of the expression pattern of cSmad6, bmp-2, bmp-7, and Nkx2-5 in the developing heart at stage 20 and stage 26–28
by in situ hybridization on tissue sections. The levels of sectioning are indicated in the diagrams of the heart on the left. (A) At stage 20,
when septation of the heart had begun, cSmad6 was expressed throughout the heart, both in the myocardium and in the endocardium. High
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
s
s
a
s
M
r
o
d
u
c
m
e
r
e
(
m
w
c
t
p
a
t
s
o
o
m
c
p
i
a
d
m
t
55Smad6 in Chick Cardiac Developmentectodermal ridge. cSmad6 transcript levels were elevated at
the anterior and posterior limb bud margins, and low
expression was also found in the apical ectodermal ridge
(Fig. 4H). At the time when digits started to form, cSmad6
expression was restricted to the interdigital zones (Figs. 4I
and 4J).
Expression of BMP-Pathway-Specific cSmad1
and cSmad5 in the Cardiogenic Region
As described above, the spatiotemporal patterns of
cSmad6 expression resembled those of bmp-2, -4, and -7 in
the developing heart. Since several in vitro studies have
uggested that Smad6 was a negative regulator of BMP
ignaling (Imamura et al., 1997; Topper et al., 1997; Hata et
l., 1998), we expected that positive mediators of BMP
ignaling, such as Smad1 and Smad5 (Kretzchmar and
assague´, 1998), might also be expressed in the cardiogenic
egion. This prompted us to survey the expression pattern
f these two genes, during the early stages of cardiac
evelopment.
Partial cDNAs of cSmad1 and cSmad5 were isolated
sing the RT-PCR strategy described here in detail for
Smad6. Corresponding riboprobes were used for whole-
ount in situ hybridization analysis. cSmad1 and -5 were
xpressed along the primitive streak and in the anterior
egion of stages 6–7 embryos (Figs. 5A and 5B). The cSmad1
xpression pattern (Fig. 5A) was similar to that of the BMPs
Figs. 2D–2F) and of cSmad6 (Fig. 2B), but expression was
ore diffuse including anterior lateral and medial areas and
eaker (note riboprobes of similar length were used for
Smad1 and cSmad5). Of note, cSmad1 was expressed in
he cardiogenic region (Fig. 5A) and continued to be ex-
ressed in the cardiac tissue to at least stage 7 (Fig. 5E),
lthough expression levels were low when compared with
hat of cSmad6 (Fig. 2H). cSmad5 was expressed in neuro-
ectoderm and anterior medial area of the embryo at stages
6–7, but transcripts were not found in the anterior lateral
cardiogenic region, suggesting that this gene was not in-
volved in heart formation at this stage. Cardiac cells exhib-
ited weak cSmad5 expression at stage 8 (Fig. 5F). Although
cSmad1, a positive regulator of BMP signaling, is expressed
yo, myocardium; otc; outflow tract endocardial cushion, p, posterio
runcus; v, ventral.
Copyright © 1999 by Academic Press. All rightFIG. 4. cSmad6 expression in developing eyes and limb buds. (A)
cSmad6 expression in the developing eye was first seen at stage 10
and persisted through stage 17 (B, C). At first the expression was
located in the neuroectoderm of the optic vesicle (D). Once the
surface ectoderm contacting optic vesicle started to invaginate,
cSmad6 expression was also detectable in the forming lens placode
(E). At stage 17 (F), cSmad6 was expressed only in the lens vesicle.
(G) At stage 18, cSmad6 was expressed in nascent limb buds. (H) In
a stage 20 wing bud expression was high at the anterior and
posterior margins, regions that also express bmps. (I, J) At stage 30,
cSmad6 was expressed in the interdigital zones of the wings (I) and
leg (J). Abbreviations: lp, lens placode; lv, lens vesicle; oc, optic cup;
ov, optic vesicle; se, surface ectoderm.levels of cSmad6 expression were observed in the myocardium at the atrioventricular junction. (B) bmp-2 was expressed only in the
myocardium at the atrioventricular junction. bmp-7 (C) and Nkx2-5 (D) were expressed in entire myocardium, similar to cSmad6. (E) At
tage 28, cSmad6 expression was detected in the myocardium, the endocardium, and the atrioventricular endocardial cushion. Expression
f cSmad6 was accentuated in the forming interventricular septum (I) and aorticopulmonary septum (J). (H, M) Nkx2-5 mRNA was found
nly in the myocardium and not in the endocardial cushion and the aorticopulmonary septum. (G, L) bmp-7 expression was seen in the
yocardium, from atria, through ventricles until conus muscles. (F, K) bmp-2 expression was limited to the portions of the myocardium
ontributing to septum formation, and there was no bmp-2 expression in the endocardial cushion. (N) Diagrams showing the overlapping
atterns of expression of cSmad6 and bmp-2, -4, and -7 at stage 26–28. The four-chamber view of the heart representing the level of E–H
s shown on the left, and the section of outflow tract representing the level of J–M is on the right. Abbreviations: a, anterior; aps,
orticopulmonary septum; avc, atrioventricular endocardial cushion; avg, atrioventricular groove; avj, atrioventricular junction; cns, conus;
, dorsal; ecc, endocardial cushion; end, endocardium; ias, interatrial septum; ivs, intraventricular septum; la, left atrium; lv, left ventricle;r; pv, primitive ventricle; ra, right atrium; rv, right ventricle; tr,
s of reproduction in any form reserved.
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56 Yamada et al.in the cardiogenic region, expression is clearly less cardiac-
specific than that seen for cSmad6, indicating that BMP
specificity in the heart is primarily affected by the inhibi-
tory SMADs, cSmad6 in this case.
Regulation of cSmad6 by BMPs
The strong expression of cSmad6 in the cardiogenic
FIG. 5. Expression of cSmad1 and cSmad5 in stage 6–7 embryos.
(A) cSmad1 was expressed broadly in the anterior part of the
embryo including the cardiogenic region, but expression was more
diffuse and weaker than that of cSmad6. (B) cSmad5 was expressed
in neuroectoderm and anterior medial area of the embryo, but
transcripts were not found in the anterior lateral cardiogenic
region. (2) Ectopic BMP-2 induced the expression of cSmad6 and
Nkx2-5 in the anterior medial region of stage 5 chick embryos. (C,
G) BMP-2-induced expression of cSmad6 in cells surrounding the
beads (red arrowhead in G) in a domain medial to endogenous
cSmad6 expression (black arrow in G). (D) BMP-2 also induced
Nkx2-5 expression (see also Schultheiss et al., 1997). In contrast,
neither cSmad1 (E) nor cSmad5 (F) expression was induced by
BMP-2. BMP-2-soaked beads are marked by an asterisk, and control
beads in (C) and (G) are marked by “c.” Abbreviations: hn, Hensen’s
node.egion as well as the expression of BMPs and Nkx2-5
uggested that cSmad6 might have a specific active func-
Copyright © 1999 by Academic Press. All rightion in the signaling pathway between BMPs and Nkx2-5
uring the period of cardiac induction. Schultheiss et al.
1997) showed that BMP-2 could induce Nkx2-5 expression
hen BMP-2-soaked beads were implanted to the anterior
edial area of stage 5 embryos, which was normally non-
ardiogenic but competent to form cardiac tissues. We
ested whether cSmad6 could be induced by ectopic appli-
ation of BMP to this noncardiogenic tissue. Heparin–
crylamide beads or rat bone matrix particles soaked in 30
mg/ml BMP-2 were implanted into the anterior medial area
of the stage 5 embryos. The embryos were incubated for 4 to
9 h after implantation and were subsequently processed for
whole-mount in situ hybridization to evaluate the expres-
sion of cSamd1, -5, and -6 and Nkx2-5. BMP-2 induced
intense expression of cSmad6 in cells surrounding the
beads in a domain medial to the endogenous cSmad6
expression in 75% of embryos implanted (n 5 36) (Fig. 5C,
Table 1). A cross-section at the level of the implant showed
the strong induction of cSmad6 around the bead, not only
in the mesoderm but also in surrounding ectoderm and
even a part of a neural tube (Fig. 5G). A similar induction
was found for Nkx2-5 (Fig. 5D and Schultheiss et al., 1997).
We observed that release of BMP-2 from either carrier was
able to induce cSmad6. Moreover, induction was dose
dependent, in that the lower dose evoked cSmad6 expres-
sion in about half of the cases, while the higher dose was
100% effective (Table 1). Longer incubation with BMP-2
decreased the percentage of cSmad6 induction by BMP-2
(Table 1), while Nkx2-5 induction was still observed in all
cases (data not shown). Neither cSmad1 (Fig. 5E) nor
cSmad5 (Fig. 5F) was induced by BMP-2, even when the
concentration of BMP-2 was increased to 90 mg/ml.
We then asked whether cSmad6 mediated the effect of
BMP on Nkx2-5 expression or acted in some other fashion
in cardiac development. Tissue explants obtained from the
anterior medial region from stage 5 to 6 embryos were
cultured in either presence or absence of BMP-2 and were
analyzed for expression of cSmad6 and Nkx2-5 by RT-PCR
(Fig. 6A). Transcripts of Nkx2-5 were not detected in
anterior medial explants prior to incubation and 1 h after
incubation with BMP-2. By 3 h of BMP-2 treatment, how-
TABLE 1
Percentage of Embryos Which Showed cSmad6 Induction
as a Result of Local BMP-2 Release
Carrier type
Concentration
of BMP-2
Duration of treatment
4–5 h 8–9 h
Bone particle 5 mg/ml 43% (n 5 7) —
30 mg/ml 100% (n 5 12) 57% (n 5 7)
eparin bead 30 mg/ml 60% (n 5 5) —
90 mg/ml 100% (n 5 5) —Note. n, number of cases. Induction was assessed by whole-
mount in situ hybridization.
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57Smad6 in Chick Cardiac Developmentever, Nkx2-5 expression was induced and it continued for at
least 6 h. Control tissues incubated without addition of
BMP-2 did not express Nkx2-5 (Fig. 6A). cSmad6 was
detectable at low levels in nontreated anterior medial
explants, even though in situ hybridization did not show
any expression of cSmad6 in this region, probably because
of the greater sensitivity of RT-PCR. cSmad6 expression
was not changed by a 1-h long treatment with BMP-2, but
the level of cSmad6 had clearly increased after 3 h of BMP-2
treatment. Interestingly, after 6 h of BMP-2 treatment,
induction of cSmad6 expression was no longer obvious (Fig.
6A). This might be the same outcome that we have seen in
the BMP-2 beads experiment, as the reduction of percentage
of cSmad6 induction after 8–9 h of BMP-2 treatment (Table
1). It has been suggested that once it is turned on, Nkx2-5
expression persists through autoregulatory pathway (Reecy
et al., 1999); therefore, in the case of Nkx2-5, expression
observed at 6 h of BMP-2 treatment may not be a direct
FIG. 6. (A) Induction of cSmad6 and Nkx2-5 by BMP-2 in chick
explant cultures. Tissues from anterior medial (AM) region of stage
5–6 embryos were cultured in either presence (1) or absence (2) of
BMP-2. Cardiogenic tissue explants (anterior lateral tissue, AL)
were used as a positive control. Ethidium bromide staining of
RT-PCR products showed induction of both cSmad6 and Nkx2-5
within 3 h of BMP-2 treatment. After 6 h of BMP-2 treatment,
Nkx2-5 was still present, but cSmad6 induction was no longer
bvious. A low level of cSmad6 expression was always detected in
hese anterior medial explants without the presence of BMP-2,
robably because of the greater sensitivity of RT-PCR. GAPDH was
sed as an internal standard. (B) Reduction of cSmad6 expression
by the BMP antagonist Noggin. Cardiogenic mesoendoderm of
stage 4–5 embryos were incubated with (1) or without Noggin (2)
for 48 h and analyzed for the expression of cSmad6 and GAPDH by
RT-PCR. Ethidium bromide staining (right) and 32P labeling (left)
both showed a significant reduction of cSmad6 expression by
Noggin.effect of BMP-2, but reflect autoregulation. These data
suggest that induction of cSmad6 and Nkx2-5 occurs with a
Copyright © 1999 by Academic Press. All rightsimilar time course and in a parallel fashion, yet cSmad6
induction is transient while that of Nkx2-5 persists. This
result makes it less likely that cSmad6 is upstream of
Nkx2-5, but still supports the specific requirement of
cSmad6 for the induction of Nkx2-5 by BMPs.
Explants taken from anterior lateral cardiogenic region of
stage 4 chick embryos fail to differentiate into myocardial
tissue when cultured in the presence of Noggin, a secreted
protein acting as a BMP antagonist (Schultheiss et al.,
1997). Because cardiac-specific marker genes such as
Nkx2-5, GATA4, or MHC are not expressed in Noggin-
treated tissue, it is proposed that BMP signaling is required
for the differentiation of cardiogenic mesoendoderm into
cardiac tissue (Schultheiss et al., 1997). We asked whether
the level of cSmad6 was altered by the presence of Noggin.
Anterior lateral mesoendoderm from stage 4 to 5 embryos
was incubated with conditioned medium from CHO cells
stably transfected with Noggin (Lamb et al., 1993). After
48 h of incubation, RNAs were harvested and subjected to
RT-PCR to analyze expression of GAPDH, Nkx2-5, and
cSmad6. Explants incubated with Noggin-free medium (i.e.,
supernatant from nontransfected CHO cells) showed ex-
pression of Nkx2-5 as well as of cSmad6 as would be
xpected (Fig. 6B; data not shown). In contrast, tissues
ncubated with Noggin-containing CHO cell supernatant
xhibited a marked reduction of cSmad6 and Nkx2-5 ex-
pression. GAPDH, a marker gene, was not affected by the
treatment.
In summary, the expression of cSmad6 is rapidly induced
y ectopic application of BMP-2 and, moreover, endogenous
Smad6 expression is effectively blocked by Noggin, an
nhibitor of BMP signaling. These findings thus support the
ypothesis that cSmad6 expression is regulated by BMP in
he developing heart.
DISCUSSION
We have studied the pattern of expression of cSmad6 and
the regulation of this gene by BMP in the developing heart.
Pathway-specific SMAD family transduces growth factor
receptor signals to the nucleus, while others known as
inhibitory SMADs serve as negative regulators of this
process. Smad1 is an example for the first type of protein,
whereas Smad6 is a negatively acting SMAD protein. We
found that in the developing chick embryo the expression
pattern of cSmad6 resembled the expression pattern of
bmp-2, -4, and -7 (Schultheiss et al., 1997; Andre´e et al.,
1998; Fransis et al., 1994; Lyons et al., 1995; Solursh et al.,
1996; Luo et al., 1995). This was especially evident in the
developing heart where cSmad6 was expressed in the car-
diogenic region in a manner identical to that seen with
bmp-2, -4, and -7. This suggests that cSmad6 is involved in
BMP-dependent aspects of cardiogenesis. In addition to
cSmad6, the cardiogenic region also expressed cSmad1,
which is known to transduce the BMP signal (Kretzschmar
and Massague´, 1998). The link between BMP signaling and
s of reproduction in any form reserved.
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58 Yamada et al.cSmad6 expression in heart development is bolstered by
wo additional observations. First, ectopically applied
MP-2 protein induced cSmad6 expression as well as car-
diac fate markers in anterior medial explants. Second,
blockage of BMP signaling using Noggin protein downregu-
lated cSmad6 in the cardiogenic tissue (Schultheiss et al.,
1997). These findings, together with the overlapping pat-
terns of expression of bmps and cSmad6, suggest that BMPs
are necessary and sufficient for cSmad6 expression in the
cardiogenic region of the chick embryos.
The fact that inhibitory SMADs can be induced by the
ligands whose signal transduction they then inhibit has
been demonstrated in several in vitro systems (Takase et
al., 1998; Afrakhte et al., 1998; Nakao et al., 1997). Smad6
and Smad7 can be induced by TGF-b, activin, and BMP-7
fter 30–90 min of stimulation in certain cell lines that are
esponsive to these ligands. This occurs even in the pres-
nce of cycloheximide, a protein synthesis inhibitor (Nakao
t al., 1997; Afrakhte et al., 1998), and has led to the
uggestion that Smad6 and Smad7 could be direct target
enes of this signaling pathway. The induction of inhibitory
MADs by a ligand results in establishment of a negative
eedback that dampens the positive signaling activities of
igand. In the case of cardiac induction, the BMP signal
ould be transduced by the BMP-pathway-specific cSmad1
hat we found to be expressed in the cardiogenic region and
hich is not ligand inducible. As a result of such a positive
ignaling molecule, cardiac genes such as Nkx2-5, GATA4,
nd MHC are induced. In parallel, BMP would also induce
Smad6, which would then counteract the activating role
f cSmad1. We found that the induction of Nkx2-5 and
Smad6 occurred on a similar time scale, indicating that
he balance between a constitutively expressed positive
actor (cSmad1) and a ligand-inducible negative factor
cSmad6) could be important in orchestrating cardiac in-
uction as manifested by Nkx2-5 expression.
Several studies have explored the issue of BMP-dependent
egulation of other inhibitory SMADs (Tsuneizumi et al.,
997; Casellas and Hemmati-Brivanlou, 1998; Nakayama et
l., 1998b; Bhushan et al., 1998). The spatiotemporal ex-
ression pattern of Xenopus Smad7 is similar to that of
bmp-4. Ectopic BMP signaling significantly increases the
level of xSmad7 expression, whereas blocking BMP with a
dominant-negative BMP receptor decreases xSmad7 expres-
sion (Nakayama et al., 1998b). These authors suggest that
Smad7 functions directly within BMP-responsive cells in
which it modulates the amplitude or duration of BMP
signaling, similar to what we have proposed above for
cSmad6 in cardiac development. Drosophila Dad is another
inhibitor SMAD whose MH2 domain shares the highest
homology with Smad6 (Tsuneizumi et al., 1997). Dad
expression in the wing disc overlaps with the expression of
Dpp, a homolog of bmp-2 and -4, and ectopic expression of
Dpp induces the expression of Dad. Again, the response of
cells to Dpp may depend on the balance between the
transduction of Dpp signals by the positive regulator Mad
and antagonism by Dpp-inducible inhibitory Dad protein.
t
r
Copyright © 1999 by Academic Press. All rightTaken together, the mechanism of action of cSmad6 in
cardiac induction might be to keep the response to the BMP
signal at a certain level, by counteracting the Smad1-
mediated positive regulation. Conceivably, if cSmad6 failed
to be induced in the presence of BMPs, then upregulation of
BMP signaling may cause the appearance of inappropriate
cell lineages, predictably osteogenic rather than cardio-
genic. On the other hand, if cSmad6 was expressed at
greater levels than normally seen, BMP signaling might be
downregulated and as a result, all lineages induced by
BMPs, including cardiogenic lineage, may fail to appear.
The cardiogenic region at stage 5 to 6 consists of ecto-
derm, mesoderm, and endodermal layers, and cardiac induc-
tion is thought to involve signaling between these layers
(Jacobson, 1960; Jacobson and Sater, 1988; Sugi and Lough,
1994; Nascone and Mercola, 1995). Expression of Nkx2-5, a
marker for cardiac fate, is restricted to mesoderm. By
contrast, bmp-2 is expressed in endoderm (Schultheiss et
al., 1997). cSmad1 and cSmad6 transcripts are found in
endoderm and mesoderm. Assuming that these two factors
mediate the BMP-2 signal, two pathways could be envis-
aged. In an autocrine mechanism, BMP-2 could signal
within the endoderm and activate the expression of a yet
unknown factor that subsequently induces Nkx2-5 in the
overlying mesoderm via cSmad1 and cSmad6. The exis-
tence of such a hypothetical factor has previously been
postulated (Jacobson and Sater, 1988; Schultheiss et al.,
1997). Alternatively, BMP-2 could act in a paracrine fash-
ion, i.e., be secreted by endoderm and diffuse into meso-
derm and therein induce Nkx2-5 via cSmad1 and cSmad6.
cSmad6 is also expressed later during cardiac develop-
ment. Strong expression is seen in the atrioventricular
endocardial cushion and the myocardium at the site of
septum formation. We found, however, that the endocardial
tissue was devoid of bmp-2, -4, and -7 mRNA. Possibly
BMP-2 or BMP-7 synthesized in the myocardium adjacent
to the endocardial cushion could diffuse into the cushion
tissue that expresses cSmad6. This would, however, require
diffusion of these BMPs over many cell diameters. A more
likely mechanism is that in the cushion, cSmad6 modulates
the signal of another TGF-b family member. In the chick
mbryo, TGF-b1, TGF-b2, and TGF-b3 are expressed in the
endocardial cushion tissue (Choy et al., 1991; Barnett et al.,
1994; Ramsdell and Markwald, 1997; Nakajima et al.,
1998). Therefore, in this tissue cSmad6 may be involved in
modulating TGF-b signaling. It has been shown that Smad6
an associate not only with BMP type I receptor, but also
ith TGF-b type I receptor (Imamura et al., 1997). Thus it
is possible that cSmad6 mediates both TGF-b- and BMP-
signaling pathways during cardiogenesis.
The expression of cSmad6 is remarkably restricted in the
mbryo. In addition to the heart, the developing limb is a
egion where this gene is prominently expressed. In the
imb bud cSmad6 transcripts are seen in the apical ectoder-
al ridge (AER) and in underlying mesenchyme. Moreover,
here is an elevated expression of cSmad6 along the poste-
ior limb bud margin, a region that also contains the zone of
s of reproduction in any form reserved.
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59Smad6 in Chick Cardiac Developmentpolarizing activity (ZPA). Both, the AER and ZPA express
bmp-2 and bmp-4 (Fransis et al., 1994) and it seems likely
that cSmad6 regulates the action of these growth factors in
he developing limb. Later in limb development, pro-
rammed cell death occurs in the interdigital region. Stud-
es with dominant-negative BMP–receptor constructs have
hown that such programmed cell death depends on BMP
ignaling (Zou and Niswander, 1996). The expression pat-
ern of cSmad6 suggests that the response of cells destined
o undergo apoptosis in response to BMP may also involve
Smad6.
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